On Invalid Date, Bio Techne (NASDAQ: TECH) reported Q4 2023 earnings per share (EPS) of $0.17, up 46.88% year over year. Total Bio Techne earnings for the quarter were $27.47 million. In the same quarter last year, Bio Techne's earnings per share (EPS) was $0.32.
As of Q1 2024, Bio Techne's earnings has grown -15.57% year over year. This is 67.41 percentage points lower than the US Biotechnology industry earnings growth rate of 51.84%. Bio Techne's earnings in the past year totalled $224.16 million.
What is TECH's earnings date?
Bio Techne's earnings date is Invalid Date. Add TECH to your watchlist to be reminded of TECH's next earnings announcement.
What was TECH's revenue last quarter?
On Invalid Date, Bio Techne (NASDAQ: TECH) reported Q4 2023 revenue of $272.60 million up 0.37% year over year. In the same quarter last year, Bio Techne's revenue was $271.58 million.
What was TECH's revenue growth in the past year?
As of Q1 2024, Bio Techne's revenue has grown 2.25% year over year. This is 163.36 percentage points lower than the US Biotechnology industry revenue growth rate of 165.61%. Bio Techne's revenue in the past year totalled $1.14 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.